Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01F MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
L01FY Combinations of monoclonal antibodies and antibody drug conjugates
L01FY02 Nivolumab and relatlimab
D12334 Nivolumab and relatlimab <US>
Drug groups [BR:br08330]
Antineoplastic
DG02938 Immune checkpoint inhibitor
D12334 Nivolumab and relatlimab
Drug classes [BR:br08332]
Antineoplastic
DG02938 Immune checkpoint inhibitor
D12334 Nivolumab and relatlimab
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D12334
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D12334